IFP Advisors
RCUS icon

IFP Advisors’s Arcus Biosciences RCUS Stock Holding History

IFP Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$465 Hold
18
– – ﹤0.01% 4697
2026
Q2 		$555 Hold
18
– – ﹤0.01% 4662
2026
Q1 		$389 Hold
18
– – ﹤0.01% 4482
2025
Q4 		$429 Hold
18
– – ﹤0.01% 4324
2025
Q3 		$245 Buy
+18
New +$187 ﹤0.01% 4355
2025
Q2 		– Hold
0
– – – 4178
2025
Q1 		– Sell
-65
Closed -$754 – 4195
2024
Q4 		$1.03K Buy
+65
New +$1.06K ﹤0.01% 3270

Other funds holding RCUS

Gilead Sciences
Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

IFP Advisors's RCUS Position: Q3 2026 in Review

IFP Advisors held its Arcus Biosciences (RCUS) position steady in Q3 2026 at 18 shares worth $465. The position accounts for ﹤0.01% of the portfolio, ranked #4697.

IFP Advisors first reported a position in RCUS in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.03K in Q4 2024. 111 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.

  • IFP Advisors held 18 shares of Arcus Biosciences worth $465 as of Q3 2026.
  • IFP Advisors left its Arcus Biosciences share count unchanged in Q3 2026.
  • Arcus Biosciences made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4697 holding.
  • IFP Advisors first reported a position in Arcus Biosciences in Q4 2024 and has held it in 6 quarters since.
  • IFP Advisors's Arcus Biosciences position peaked at $1.03K in Q4 2024.
  • 111 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.